Centrica looks past a weaker start to the year as nuclear decision looms

  • Centrica PLC's (LSE:CNA) first-half earnings may have underwhelmed, but investors are being asked to look beyond the short-term noise. Despite a softer outlook for 2025, UBS has reaffirmed its 'buy' rating and nudged up its price target from 175p to 180p, suggesting more than 13% upside from the current share price of 159p.